2 completed, 1 active not recruiting. 2 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 4 | 1 | Active not recruiting 1 |
Follow H5N1 Virus: new trials by email Literature Review of H5N1 Virus trials Research Report on H5N1 Virus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunogenicity and Safety of 2 Doses of Avian Influenza A (H5N1) Vaccine Administered 3 vs. 8 Weeks Apart H5N1 vaccine (Arepanrix), Saline (as a placebo) - H5N1 Influenza, H5N1 Virus | Phase 4 | Active not recruiting | Canadian Immunization Research Network | 312 | 2025-10-14 | 2026-01-16 |
| Phase I Open-Label Study of Recombinant DNA Plasmid Vaccine, VRC-AVIDNA036-00-VP, Encoding for Influenza Virus H5 Hemagglutinin Protein Given Intradermally VRC-AVIDNA036-00-VP - Influenza A Virus, H5N1 Subtype, Influenza A Virus | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 44 | 2007-06-18 | 2017-07-02 |
| Safety Study of Avian Flu Vaccine VRC-AVIDNA036-00-VP - Influenza A Virus, H5N1 Subtype, Influenza A Virus | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 45 | 2006-12-04 | 2017-07-02 |
Animal Diseases (3) · Bird Diseases (3) · Infections (3) · Orthomyxoviridae Infections (3) · RNA Virus Infections (3) · Virus Diseases (3)
Saline Solution (1) · Sodium Chloride (1) · arepanrix (1)
National Institute of Allergy and Infectious Diseases (NIAID) (2) · Canadian Immunization Research Network (1)
United States (2) · Canada (1)
Joanne M Langley (1)